Mettler-Toledo International (NYSE:MTD) Upgraded at Wall Street Zen

Mettler-Toledo International (NYSE:MTD) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.

Other analysts also recently issued research reports about the company. Citigroup boosted their price objective on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Morgan Stanley dropped their target price on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Stifel Nicolaus upped their price target on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday, November 10th. The Goldman Sachs Group assumed coverage on shares of Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective for the company. Finally, Barclays lowered their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research report on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and an average price target of $1,435.42.

Mettler-Toledo International Stock Performance

Shares of NYSE:MTD opened at $1,362.59 on Friday. The company has a market capitalization of $27.70 billion, a PE ratio of 32.35, a price-to-earnings-growth ratio of 2.85 and a beta of 1.42. The stock has a fifty day moving average of $1,416.03 and a 200-day moving average of $1,363.09. Mettler-Toledo International has a one year low of $946.69 and a one year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $12.76 by $0.60. The business had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The company’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period in the previous year, the firm posted $12.41 EPS. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. As a group, research analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 236 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $1,418.58, for a total value of $334,784.88. Following the transaction, the insider owned 159 shares in the company, valued at approximately $225,554.22. This represents a 59.75% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider La Guerroniere Marc De sold 6,055 shares of Mettler-Toledo International stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $1,488.18, for a total transaction of $9,010,929.90. Following the sale, the insider directly owned 187 shares of the company’s stock, valued at $278,289.66. This trade represents a 97.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 9,116 shares of company stock valued at $13,473,111. Corporate insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Geneos Wealth Management Inc. lifted its holdings in shares of Mettler-Toledo International by 83.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after buying an additional 30 shares during the last quarter. IFP Advisors Inc raised its position in Mettler-Toledo International by 542.9% during the second quarter. IFP Advisors Inc now owns 90 shares of the medical instruments supplier’s stock valued at $106,000 after acquiring an additional 76 shares in the last quarter. Apollon Wealth Management LLC raised its position in Mettler-Toledo International by 3.9% during the second quarter. Apollon Wealth Management LLC now owns 349 shares of the medical instruments supplier’s stock valued at $410,000 after acquiring an additional 13 shares in the last quarter. CWM LLC lifted its stake in Mettler-Toledo International by 32.1% in the second quarter. CWM LLC now owns 868 shares of the medical instruments supplier’s stock valued at $1,020,000 after acquiring an additional 211 shares during the last quarter. Finally, MGO One Seven LLC bought a new stake in Mettler-Toledo International in the second quarter worth approximately $204,000. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.